Search This Blog

Showing posts with label Dr. Jensen. Show all posts
Showing posts with label Dr. Jensen. Show all posts

Wednesday, April 20, 2016

Cause for Celebration

The Katie Gerstenberger Endowment for Cancer Research was created and is supported by gifts from family and friends of Katie Gerstenberger, who died at the age of 12 after enduring 10 months of grueling chemotherapy and an 18-hour surgery.
We founded this endowment with the aim to change the way cancer is treated, and to prevent other families from enduring the heartache which Katie and we have experienced.

The wonderful news we have to share is the fact that in the eight years since her passing, Katie's endowment has grown to over $310,000, and donates its income to fund immunotherapy research, which is today saving lives, without chemotherapy or surgery!

In 2015, the endowment sent $11,073 of its income to support the research of Dr. Michael Jensen in his lab at the Ben Towne Center for Childhood Cancer Research. The remission rate in their work has been 91%, and these are cases of relapsed cancer (which is more difficult to treat)! It is gratifying to see this work succeed, and gain even more momentum. If you would like to read an update on this work, please follow this link. One of Dr. Jensen's colleagues is Dr. Rebecca Gardner, who was on Katie's care team, and is featured in the article with him.

Thank you, family and friends who have supported, and continue to support, Katie's endowment. Seattle Children's Hospital will be sharing further updates in the coming months, so stay tuned! If you'd like to know how you can help, please contact me at karengberger at gmail dot com.

Wednesday, April 1, 2015

Wonderful News: Your Generosity

I just received an update on the balance of the Katie Gerstenberger Endowment for Cancer Research, and it is wonderful news.
The current funds in the endowment (which generates income in support of research at the Jensen Lab at the Ben Towne Center for Childhood Cancer Research in Seattle, led by Dr. Michael Jensen) total
 $295,423.00

Thank you  
for making this dream a reality! 
Over a quarter of a million dollars, 
dedicated to cancer research. 
What a fabulous legacy for Katie.

Tuesday, January 20, 2015

Juno Therapeutics in the News (T-Cell Therapy)

Juno Therapeutics has been in the news lately; they "went public" on the NASDAQ exchange recently (you can look up the stock with the symbol JUNO). Juno was also featured in Seattle Business magazine last month, in a fascinating article about the business climate for biotechnology here in Seattle. The article explores how Juno fits into that picture, and is well worth the time it takes to read; you can access it easily by clicking the link HERE.

The day we have prayed for is drawing closer through this research - the day when we stop poisoning cancer patients with chemotherapy and radiation, and strengthen their bodies using their own immune system's T-cells. Katie would be thrilled - somehow, I believe that she IS thrilled.

Thursday, September 25, 2014

10 Lives Saved

You may have seen (on my other blogs, or on the Ben Towne Foundation website and facebook page) that we attended the Ben Towne Foundation's #BTFBenefit2014 last Friday evening. What you may not know (though I hope you do) is that the Katie Gerstenberger Endowment supports the same research that the Ben Towne Foundation funds. The income which accrues on the principal of the endowment goes to the Ben Towne Center for Childhood Cancer Research.
#BTFBenefit2014
On Friday evening, we celebrated this news from the Ben Towne Center:
- a clinical trial for the treatment of neuroblastoma has been submitted to the FDA for approval and
- 10 PATIENTS who have been treated with T-cell therapy ARE IN REMISSION!

Ten patients who had experienced relapse, who had no other treatment options - whose hope for a cure was completely exhausted, and were facing death - those ten children are now in remission.

Ten families are not heartbroken today - parents, siblings, extended family and community - have their precious, beloved child with them. Ten families did not have to sign "do not resuscitate" forms, did not have to request hospice care, did not have to plan a memorial service, pick a headstone, face an empty bedroom.

Ten.

Your donations to the Katie Gerstenberger Endowment support this ground-breaking, life-restoring work. Thank you!

Monday, August 11, 2014

2014 Financial Report

We received the 2014 Annual Financial Report for the Katie Gerstenberger Endowment for Cancer Research. It contains GOOD news.
  • Market Value on 3/31/2013: $192,743
  • Contributions between 4/1/13 and 3/31/14: $27,820
  • Market Value as of 3/31/14: $238,316
  • Distributions to Program (to the Jensen Lab at the Ben Towne Center for Childhood Cancer Research): $8,496
That means that your generous donations and support have generated eight thousand four hundred and ninety-six dollars THIS YEAR for cancer research!

This research has already saved the lives of two cancer patients who had no other treatment options. The research will continue and expand to other types of cancers because of the continuing distributions generated by the principal of this endowment (combined with other sources). Your gifts are giving hope, care and cure to patients and their families - and saving lives.

These breakthroughs in curing cancer come just seven years after Katie's passing, and they are a beautiful legacy for her.
 Thank you for helping to create that legacy!

Tuesday, February 18, 2014

Another Patient in Remission!

Seattle Children's Hospital's Ben Towne Center for Childhood Cancer Research has announced that the second patient in the (PLAT)-01 clinical trial of therapy for relapsed leukemia at the is in remission! This is the work which the Katie Gerstenberger Endowment (and the Ben Towne Foundation) supports. Both Dr. Gardner and Dr. Park treated Katie when she was in the hospital, and she would be thrilled with their success, and the good work which her endowment is supporting and moving forward.

You can read all about it here:
From hopeless to cancer free

Wednesday, January 15, 2014

Phase II Clinical Trial Approved & JUNO THERAPEUTICS


Ben Towne Center for Childhood Cancer Research Profile from ben towne foundation on Vimeo.

Just before Christmas, we received this good news from the Ben Towne Center for Childhood Cancer Research's Jensen Lab (which the Katie Gerstenberger Endowment supports):
“The FDA’s authorization of our second pediatric leukemia T cell therapy protocol is a milestone for the Ben Towne Center for Childhood Cancer Research. This trial will allow us to treat patients age 12 months-27 years of age who are in the worst possible situation—relapse after bone marrow transplantation.  We will be able to enroll and treat patients on an accelerated time table with our latest version of the reprogrammed T cell product that was developed in our laboratories here at BTCCCR with the help of our generous donors.  One exciting element of this trial called PLAT-02 is that it is a combined Phase I trial to establish safety that then rolls in to a larger Phase II trial to establish efficacy. 

"We know for many children that we treat, this will be their last chance to beat their leukemia.” - Michael C. Jensen, MD
Dr. Rebecca Gardner (who speaks in the video above) was one of Katie's doctors.
Dr. Pollard on the left, Katie and Dr. Gardner on the right, December 2006
 And there is more good news: the formation of "a new biotechnology company focused on bringing forward novel immunotherapies for cancer," called Juno Therapeutics. This is a joint venture of Seattle Children's Research Institute (of which the BTCCCR is part), Fred Hutchinson Cancer Research Center and Memorial Sloan-Kettering. You can visit their website to learn more: junotherapeutics.com
The site contains press releases with fabulous news of over $145 million in venture capital committed to supporting this research. You can access the press releases here:

Two scientists who we know personally (and admire deeply), Kendall Mohler, Ph.D. and Dr. Michael Jensen, are key  members of the Juno team. I am thrilled to know that the torch is being carried by such compassionate, brilliant, talented, accomplished scientists. 

The potential of this venture is unlimited. It is what I dreamed might be possible in the first dark months after Katie's passing. To see it happening, right here in Seattle, is truly a dream-come-true, and an answer to prayers.

Tuesday, November 19, 2013

FABULOUS NEWS!



We have FABULOUS news at the Katie Gerstenberger Endowment for Cancer Research. Because of your generosity - you, our family and friends - the value of the endowment is now at an all-time high of $224,168!
This is beyond our wildest dreams of what would be raised in Katie's memory, and she would be thrilled. She would also be thrilled with the advancements in cancer research, and the hope that this means for patients like her. Here is a news flash from the Ben Towne Center for Childhood Cancer Research (which Katie's endowment supports):

  "NEWSFLASH FROM THE BEN TOWNE CENTER:
Photo: NEWSFLASH FROM THE BEN TOWNE CENTER:

The second clinical trial application using reprogrammed T cells was submitted to the FDA today! This trial (PLAT-02) will be for relapsed pediatric acute lymphoblastic leukemia (post-transplant).

Our thanks to the entire team at the Ben Towne Center for your incredible efforts!
"The second clinical trial application using reprogrammed T cells was submitted to the FDA today! This trial (PLAT-02) will be for relapsed pediatric acute lymphoblastic leukemia (post-transplant).

"Our thanks to the entire team at the Ben Towne Center for your incredible efforts!"
The principal of Katie's endowment remains in trust at Seattle Children's Hospital; the income from Katie's endowment is donated to the Ben Towne Center for Childhood Cancer Research (BTCCCR) each year (usually 2x a year).

If you would like to take a tour of the BTCCCR, let me know and I will help you arrange it.

Thursday, October 10, 2013

More Good News

1100 people gathered for the Ben Towne Foundation's BENefit 2013 (Image: Bryce Covey Photography)
Around here, autumn is the time when many charities host fundraisers. Gregg and I are always pleased to attend the Ben Towne Foundation's annual BENefit. We've had the privilege of being an active part of this event from its inception, and watching it grow each year lifts my heart like no other "gala" can.

Though the thing that drew us together with the Townes is the worst thing that has ever happened to us, our friendship goes far beyond that loss. It includes our sense of humor, commitment to family, a lot of coincidences, shared tastes and sensibilities, fierceness, passion and joie de vivre. It is pure pleasure to be counted among their friends and supporters, and to do all that we can to share their message and raise awareness of it.
Jeff & Carin Towne with Dr. Michael Jensen (Image: Bryce Covey Photography)
Though there are always some moments during the program that make me cry, most of my emotions at the BENefit are joyful, because the Ben Towne Foundation is getting the job done - making my dreams of a cure for pediatric cancer come true, in this time and place. Through their efforts, the pace is accelerating here in Seattle under the leadership of Dr. Mike Jensen and Dr. Rebecca Gardner (two special favorites of mine), among others. The Katie Gerstenberger Endowment for cancer research supports their laboratory.
Reba & Mary-Jane with me
Joining us at our table were my parents, brother Jim and sister-in-law Caroline, and our friends Reba, Bill, Mary-Jane and Brian. Let me give you a few statistics about our table: 60% of us had our only daughter die from pediatric cancer. Every single person at our table (100%) had suffered the loss of someone close to them as a result of pediatric cancer. For 20% of our table, it was their ONLY child (100% of the children in that family). All of us want to see this disease wiped out, with as few side effects, as quickly as possible. And we were in the right place to help the researchers accomplish that.

The news is good, my friends: the first patient in the clinical trial of T-Cell therapy continues to enjoy remission, gained after only 9 days of treatment, with side effects of flu-like symptoms during that time. Her mother was a guest at the BENefit, and spoke to the audience about what our support for this therapy means to her. The next patient is ready to enroll, and it looks as if the clinical trial will soon be expanded to include a much broader range of ages - open for more patients to be treated and cured in this new, non-toxic way!

Did you know that it can cost 10 times more to treat a child with traditional chemotherapy than with T-Cell therapy - and surgery costs even more? The bill for Katie's care was in the neighborhood of a million dollars, for which we were (thank God) covered by medical insurance - but there are many whose finances are completely wiped out by such treatment, and without the promise of a cure!

Think of it this way: you could spend $350,000 for a patient to endure chemo, which can cause secondary cancers, organ damage, susceptibility to infections and reproductive problems - or $30,000 for a patient to have T-Cell therapy, with no long-term damage whatsoever, and continuing immune-system support for remission. Which would you choose for your child - or for yourself? What would you like to see become the "norm?"

On this day - the very one on which Katie was admitted into the hospital in 2006 - people such as Katie, Carin and Jeff Towne, Dr. Jensen and Dr. Gardner inspire me. Who (or what) inspires you to give?

Wednesday, July 10, 2013

HOPE is HERE, NOW, Because of YOU



Thank you.
You have made this miracle possible with your donations to the Katie Gerstenberger Endowment, through our support of the Ben Towne Center for Childhood Cancer Research.

Katie would be happy and proud that her memory inspired you to give to her endowment, and even more delighted that your support has brought HOPE, HERE and NOW, for cancer patients. 
This means we are closer to an end to suffering from treatments, damaging side effects and more, Because of Katie, 
and because of you.
THANK YOU 
for helping to make this dream come true!

Sunday, October 7, 2012

HUGE, Wonderful News



Thank You to our donors for your generosity to the Katie Gerstenberger Endowment for Solid Tumor Research.

 update on the endowment’s growth:  
Due to your generosity and market growth,  
as of March 31, 2012, the market value of the endowment is $167,373. This is a great increase over March 2011, when the total was $140,554. Thank you!

 what we are doing with the endowment’s income:  last summer, Seattle Children’s Hospital’s Research Institute opened the Center for Childhood Cancer Research (recently re-named the Ben Towne Center for Childhood Cancer Research in memory of the son of our friends, Carin and Jeff Towne. You can learn more about the Townes’ work at www.bentownefoundation.org.)
Dr. Michael Jensen, the director of the new center, is a man of vision, passion and compassion, who is pioneering the use of T-cells to kill cancer, rather than toxic chemotherapy and radiation. His work is a promising new kind of treatment, which has just (last week) received approval from the FDA to commence clinical trials! 
No chemotherapy, no radiation, no harmful side effects nor long-term disability, no secondary cancers - this is a treatment protocol of which we have dreamed for many years, and it is about to begin.
The income from the Katie Gerstenberger Endowment for Cancer Research is funding this work. Your contributions are supporting research to change the way cancer is treated – for the better.

an invitation to see what your donations are accomplishing:  Dr. Jensen has kindly offered to conduct a private tour of the research center (in downtown Seattle at 1100 Olive Way) for our endowment's friends and donors on Thursday, October 11, 2012 at 1:00 P.M.  If you would like to tour the center, meet Dr. Jensen and learn more about the research our endowment is supporting, please let me know by emailing me at karenlboren@yahoo.com. We would love to share this experience with you, and we need to know how many are planning to join us.

We are profoundly grateful to be participating in this research, and grateful to you for your donations, which are making this possible.